Last --
Change Today 0.00 / 0.00%
Volume 0.0
656 On Other Exchanges
656 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

fosun international (656) Snapshot

Previous Close
Day High
Day Low
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for FOSUN INTERNATIONAL (656)

Related News

No related news articles were found.

fosun international (656) Related Businessweek News

View More BusinessWeek News

fosun international (656) Details

Fosun International Limited, through its subsidiaries, is engaged in pharmaceuticals and healthcare, property, steel, mining, and asset management businesses primarily in Mainland China and Hong Kong. Its Pharmaceuticals and Healthcare segment is involved in the research and development, manufacture, sale, and trade of pharmaceutical and healthcare products for the therapeutic areas of metabolism, digestive tract, cardiovascular, nervous system, and anti-infection. The company’ Property segment is engaged in the development and sale of properties; and provision of sales agency and consulting services. Fosun International Limited’s Steel segment is engaged in the manufacture, sale, and trade of iron and steel products. Its principal products include medium and heavy plates, including high strength ship plates, boiler and pressure vessel plates, and pipeline steel plates; and bearing steel, as well as hot rolling medium wide strips, cold rolling medium wide strips, hot rolling narrow strips, cold rolling narrow strips, hot rolling coils, reinforcing bars and wire rods, and sectional materials. The company’s Mining segment is involved in the mining and ore processing of various metals. This segment is primarily engaged in the mining and sale of iron ore. Fosun International Limited’s Asset Management segment is involved in the asset management business through the platform, such as corporation funds, partnership funds, and trusts. The company’s Insurance segment provides life insurance, accident insurance, serious disease insurance, universal insurance, property and casualty insurance, and medical insurance, as well as reinsurance products. Fosun International Limited’s Investment segment invests in strategic associates, as well as private equity, secondary market, limited partner, and other investments. The company was founded in 1992 and is based in Shanghai, the People’s Republic of China. Fosun International Limited is a subsidiary of Fosun Holdings Limited.

36,000 Employees
Last Reported Date: 04/14/14
Founded in 1992

fosun international (656) Top Compensated Officers

Vice Chairman, Chief Executive Officer and Me...
Total Annual Compensation: CNY6.2M
President, Executive Director, Member of Nomi...
Total Annual Compensation: CNY6.2M
Total Annual Compensation: CNY6.3M
Chief Financial Officer, Senior Vice Presiden...
Total Annual Compensation: CNY4.8M
Senior Vice President and Executive Director
Total Annual Compensation: CNY4.7M
Compensation as of Fiscal Year 2013.

fosun international (656) Key Developments

Fosun Reportedly Submits Bid For LIG

Fosun International Limited (SEHK:656) is said to be interested in LIG Insurance Co., Ltd. (KOSE:A002550). According to the news report, Fosun International has reportedly submitted a bid to acquire around a 20.96% equity stake in LIG Insurance for around $330 million. According to the report the stake would represent 12.5 million shares in LIG. According to LIG Spokesman, the deal is scheduled to be finalized in the coming weeks.

FOSUN CAPITAL GROUP Presents at AVCJ Private Equity & Venture Forum - China 2014, Jun-11-2014 11:45 AM

FOSUN CAPITAL GROUP Presents at AVCJ Private Equity & Venture Forum - China 2014, Jun-11-2014 11:45 AM. Venue: 2 Jianguomenwai Street, Beijing 100022, Chaoyang District, Beijing Province, China. Speakers: James Zheng, Managing Director.

HCA Holdings Reportedly Frontrunner For Healthscope

HCA Holdings, Inc. (NYSE:HCA) is the frontrunner with a $5 billion bid for the acquisitions of Healthscope Limited. It is known to have beaten rival bidders for Healthscope, including Fosun International Limited (SEHK:656) and IHH Healthcare Berhad (KLSE:IHH). HCA’s executives were known to be in Australia working on the final stages of the deal. Sources stated that Healthscope's owners, TPG Capital, L.P. and The Carlyle Group LP (NasdaqGS:CG), were still considering whether they could raise more money from an initial public offering. A well-placed source said a deal would not be announced until the end of May 2014, perhaps even early June 2014. Others alternatives are being considered including selling the operating business, which is valued at about $3 billion and $1.2 billion property portfolio separately. The sale process of Healthscope has also attracted Wesfarmers Limited (ASX:WES), which is reported to be weighing up a $3 billion offer for the operating business. On the property side, Lend Lease Group (ASX:LLC), GPT Group (ASX:GPT) and Parkway Life Real Estate Investment Trust (SGX:C2PU) are known to have made offers for the portfolio of hospitals and healthcare clinics.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
656:HK $10.18 HKD -0.12

656 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 656.
View Industry Companies

Industry Analysis


Industry Average

Valuation 656 Industry Range
Price/Earnings 9.4x
Price/Sales 1.0x
Price/Book 1.3x
Price/Cash Flow 10.1x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOSUN INTERNATIONAL, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at